---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-089293"
form_type: "8-K"
ticker: "NWBO"
cik: "0001072379"
company_name: "NORTHWEST BIOTHERAPEUTICS INC"
filed_at: "2026-07-31T21:17:23+00:00"
generated_at: "2026-07-31T21:18:11.347018+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# NW Bio enters $4.9M convertible note financing with Yorkville; also secures $50M standby equity facility

## Summary
- $4.9M convertible promissory note, 12-month term, no interest, 5% OID, convertible at discount to market.
- Yorkville also acquired warrant to purchase up to $2M shares at $0.205 per share.
- Standby equity subscription agreement for up to $50M in common shares, available after note repaid/converted, 24-month term.
- Proceeds for general corporate purposes including lead product and in-licensed portfolios.
- Prior standby equity subscription agreement cancelled.

## SEC filing metadata
- accession: 0001104659-26-089293
- form_type: 8-K
- ticker: NWBO
- cik: 0001072379
- company_name: NORTHWEST BIOTHERAPEUTICS INC
- filed_at: 2026-07-31T21:17:23+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1072379/000110465926089293/0001104659-26-089293-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1072379/000110465926089293/tm2620800d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-089293
- JSON: https://secwatch.observer/filing/0001104659-26-089293.json
- Plain text: https://secwatch.observer/filing/0001104659-26-089293.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.